Literature DB >> 7982672

Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization.

S J Hamilton-Dutoit1, G Pallesen.   

Abstract

The Epstein-Barr virus (EBV) is associated with an increasing range of reactive and neoplastic lesions. There is a need for a sensitive and specific method for detecting latent EBV in routine histological sections. We report the use of a highly sensitive paraffin section RNA/RNA in situ hybridization (ISH) technique using digoxigenin-labelled antisense riboprobes for demonstrating EBV encoded small RNAs (EBERs), EBV gene products that are transcribed in abundance during latent EBV infection. We applied EBER-ISH to 846 paraffin embedded specimens, including cases of reactive lymphoid hyperplasia (n = 28), infectious mononucleosis (16), Burkitt's lymphoma (44), immunodeficiency-associated lymphomas in transplant recipients (9) and AIDS patients (128), Hodgkin's disease (130), CD30 antigen positive lymphomas (106), peripheral T-cell lymphomas (104), sporadic B-cell non-Hodgkin's lymphomas (162), undifferentiated nasopharyngeal carcinoma (86), salivary gland lymphoepithelioma (11), and oral hairy leukoplakia (5). Strong, reproducible EBER staining was seen in EBV latently infected cells in archival surgical biopsy and autopsy specimens. EBER-ISH is specific, has a sensitivity comparable to that of the polymerase chain reaction, and is now the method of choice for the in situ detection of latent EBV infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982672     DOI: 10.1111/j.1365-2559.1994.tb01565.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

Review 1.  Molecular diagnosis of Epstein-Barr virus-related diseases.

Authors:  M L Gulley
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

2.  Absence of Epstein-Barr virus in oesophageal squamous cell carcinoma.

Authors:  K Y Lam; G Srivastava; M L Leung; L Ma
Journal:  Clin Mol Pathol       Date:  1995-08

3.  Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.

Authors:  G Valente; P Secchiero; P Lusso; M C Abete; C Jemma; G Reato; S Kerim; R C Gallo; G Palestro
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

4.  Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases.

Authors:  M Engel; M F Essop; P Close; P Hartley; G Pallesen; C Sinclair-Smith
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

Review 5.  In situ hybridization: methods and applications.

Authors:  L Jin; R V Lloyd
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

6.  Expression of epstein-barr virus encoded nuclear antigen 1 in benign and malignant tissues harbouring EBV.

Authors:  J J Oudejans; D F Dukers; N M Jiwa; A J van den Brule; F A Grässer; P C de Bruin; A Horstman; W Vos; J van Gorp; J M Middeldorp; C J Meijer
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

7.  Acute tubulointerstitial nephritis: phenotype of infiltrating cells and prognostic impact of tubulitis.

Authors:  B Iványi; S J Hamilton-Dutoit; H E Hansen; S Olsen
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

8.  Expression of Epstein-Barr-virus-encoded small nuclear RNA in nasopharyngeal carcinomas of Aegean Turkish patients.

Authors:  Yeşim Ertan; Mine Hekimgil; Serap Karaarslan; Saliha Soydan
Journal:  Virchows Arch       Date:  2008-02-26       Impact factor: 4.064

9.  EBER oligonucleotide RNA in situ hybridization in EBV associated neoplasms.

Authors:  T Tornóczky; G Kelényi; L Pajor
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

10.  Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria.

Authors:  Hans Lassmann; Gerald Niedobitek; Francesca Aloisi; Jaap M Middeldorp
Journal:  Brain       Date:  2011-08-16       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.